OraSure Technologies to Present at Upcoming Investor Conferences
August 27 2020 - 4:30PM
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of
care diagnostic tests and specimen collection devices, and
microbiome laboratory and analytical services, today announced that
Dr. Stephen S. Tang, President and CEO, will speak to the
investment community at the following upcoming investor
conferences:
- Citi Spotlight on
Diagnostics in a COVID-19 Environment: Dr. Tang is
scheduled to participate in a panel discussion titled “Disruptors
in Diagnostic Testing” on September 1, 2020 at 12:05 PM Eastern
Daylight Time (9:05 AM Pacific Time).
- Baird’s 2020 Global
Healthcare Conference: Dr. Tang is scheduled to speak on
September 10, 2020 at 12:50 PM Eastern Daylight Time (9:50 AM
Pacific Time). Interested investors can access the live webcast of
the presentation by going to OraSure Technologies’ web site,
www.orasure.com and clicking on the Investor Info link. A replay of
the webcast will be available on OraSure Technologies’ web site for
14 days. Alternatively, you can access the live webcast of the
presentation via the following link:
https://kvgo.com/rwbaird/orasure-september-2020.
About OraSure Technologies
OraSure Technologies empowers the global
community to improve health and wellness by providing access to
accurate, essential information. Together with its wholly-owned
subsidiaries, DNA Genotek, Diversigen, CoreBiome (now operating
under the Diversigen brand), UrSure, and Novosanis, OraSure
provides its customers with end-to-end solutions that encompass
tools, services and diagnostics. The OraSure family of companies is
a leader in the development, manufacture, and distribution of rapid
diagnostic tests, sample collection and stabilization devices, and
molecular services solutions designed to discover and detect
critical medical conditions. OraSure’s portfolio of products is
sold globally to clinical laboratories, hospitals, physician’s
offices, clinics, public health and community-based organizations,
research institutions, government agencies, pharma, commercial
entities and direct to consumers. For more information on OraSure
Technologies, please visit www.orasure.com.
Company contacts:
Sam MartinArgot Partners
212-600-1902OraSure@argotpartners.com
Jeanne Mell VP Corporate Communications 484-353-1575
media@orasure.com www.orasure.com
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Aug 2024 to Sep 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Sep 2023 to Sep 2024